Immunic Inc

NASDAQ:IMUX   12:54:04 PM EDT
13.27
+0.09 (+0.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immunic Inc Stock, NASDAQ:IMUX

1200 Avenue of the Americas, Suite 200, New York, New York 10036
United States of America
Phone: +1.332.255.9818
Number of Employees: 28

Description

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohnâ??s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firmâ??s products include IMU-838, IMU-935, and IMU-856. The company is headquartered in New York, NY.